Dupilumab Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe/ Prefilled Pen)
Available Strengths: 200 mg/1.14 mL, 300 mg/2 mL
Reference Brands: Dupixent (USA)
Category:
Immune Disorder
Dupilumab is a fully human monoclonal antibody that targets the interleukin-4 receptor alpha (IL-4Rα), blocking the signaling of IL-4 and IL-13, key cytokines involved in type 2 inflammation. By modulating this immune pathway, Dupilumab helps control chronic immune-mediated conditions.
Dupilumab is available in injection (prefilled syringe/ Prefilled Pen)
and strengths such as 200 mg/1.14 mL, 300 mg/2 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Dupilumab is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Dupilumab can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing